During the past decade, NEMO conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NEMO" #1 collaborator was "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Fondazione Serena Onlus - Centro Clinico NeMO Milano" with 1 trials as a collaborator, "Insitut de Myologie Paris" with 1 trials as a collaborator, "Ludwig-Maximillians University, Munich" with 1 trials as a collaborator and "Ohio State University" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "NEMO" are "Duchenne Muscular Dystrophy" (1 trials) and "Myotonic Dystrophy 1" (1 trials). Many other conditions were trialed in "NEMO" in a lesser frequency.

The vast majority of trials in "NEMO" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "NEMO". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in NEMO, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NEMO, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".